Sumitomo Mitsui DS Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-778	Closed	-$210K	–	784
2021 Q4	$210K	Buy	778 +161	+26%	+$54.4K	﹤0.01%	748
2021 Q3	$223K	Hold	617	–	–	0.01%	731
2021 Q2	$211K	Buy	+617	New	+$204K	0.01%	746
2020 Q4	–	Sell	-2,248	Closed	-$643K	–	745
2020 Q3	$643K	Buy	2,248 +39	+2%	+$9.17K	0.02%	527
2020 Q2	$416K	Sell	2,209 -273	-11%	-$44.4K	0.01%	594
2020 Q1	$305K	Buy	2,482 +384	+18%	+$60.1K	0.01%	597
2019 Q4	$347K	Buy	2,098 +5	+0.2%	+$831	0.01%	650
2019 Q3	$256K	Buy	2,093 +155	+8%	+$20.6K	0.01%	671
2019 Q2	$240K	Sell	1,938 -495	-20%	-$62.8K	0.01%	696
2019 Q1	$321K	Buy	2,433 +402	+20%	+$54.2K	0.01%	747
2018 Q4	$284K	Buy	+2,031	New	+$269K	0.01%	735

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management's ONC Position: Q1 2022 in Review

Sumitomo Mitsui DS Asset Management sold out of BeOne Medicines Ltd (ONC) in Q1 2022, closing a stake of 778 shares — an estimated $210K sold.

Sumitomo Mitsui DS Asset Management first reported a position in ONC in Q4 2018 and held it in 11 quarters. The position peaked at $643K in Q3 2020. 239 funds tracked by Wall St. Rank hold ONC as of Q1 2022.

Sumitomo Mitsui DS Asset Management reported no remaining BeOne Medicines Ltd position as of Q1 2022 after selling out during the quarter.
Sumitomo Mitsui DS Asset Management sold 778 BeOne Medicines Ltd shares in Q1 2022, an estimated $210K.
Sumitomo Mitsui DS Asset Management first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 11 quarters.
Sumitomo Mitsui DS Asset Management's BeOne Medicines Ltd position peaked at $643K in Q3 2020.
239 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2022.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q1 2022, filed 19 Apr 2022.